In this Issue:
Empagliflozin, CV outcomes and mortality in type 2 diabetes
Home-based chronic HF management is cost effective
Neural feedback from muscle during exercise in HF
AHEAD score for long-term risk classification in acute HF
Improved ventilatory efficiency is associated with leg composition in HF
Central apnoeas/chemoreflex activation and pulmonary artery pressure in chronic HF
Ventricular remodelling after pSDF in chronic ischaemic HF
Alginate hydrogel vs. medical therapy in advanced HF
Renin-angiotensin antagonists and mortality in HF with renal insufficiency
CHA2DS2VASc for predicting outcomes in HF ±AF
HF hospitalisation risk in type 2 diabetes treated with oral hypoglycaemics
Please login below to download this issue (PDF)